Company: BAYAU
Filing Date: 2025-05-21
Form Type: 10-Q
Source: 0001641172-25-011820
Chunk: 83

Company: Bayview Acquisition Corp
Filing Date: 2025-05-21
Form: 10-Q
Item: Part II, Item 1A
Chunk 83
---
Factors that could cause our actual results to differ
materially from those in this Quarterly Report are any of the risks described in (i) our final prospectus for our Initial Public Offering
filed with the SEC on December 19, 2023, and (ii) our annual report on Form 10-K filed with the SEC on April 1, 2025. Any of these factors
could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors
not presently known to us or that we currently deem immaterial may also impair our business or results of operations. As of the date of
this Quarterly Report, there have been no material changes to the risk factors disclosed in (i) our final prospectus for our Initial Public
Offering filed with the SEC on December 19, 2023 or (ii) our annual report on Form 10-K filed with the SEC on April 1, 2025, except we
may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES
AND USE OF PROCEEDS

Use of Proceeds

On December 19, 2023, the Company
consummated the initial public offering of 6,000,000 Units (the “Units” and, with respect to the Ordinary shares included
in the Units sold, the “Public Shares”), at $10.00 per Unit, generating gross proceeds of $60,000,000.

Simultaneously with the closing
of the initial public offering, we consummated the sale of 232,500 Private Placement Units at a price of $10.00 per Unit, generating gross
proceeds of $2,325,000.

On February 23, 2023, we issued
an unsecured promissory note to our Sponsors (the “Promissory Note”), pursuant to which we received proceeds of $300,000 to
cover expenses related to the initial public offering. The Promissory Note was non-interest bearing and payable on the earlier of (i)
December 31, 2023, or (ii) the consummation of the IPO. As of December 19, 2023, there were no amounts outstanding under the Promissory
Note and the Promissory Note then expired.

19

Transaction costs related to
the issuances described above amounted to